[CLSTR]
< Back to situations

[ORGANIZATION]

Novo Nordisk A/S

Featured in 10 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [DK]

GLP-1 obesity drug rollout and market expansion

105 clusters · 510 sources · last updated

Latest: Novo Nordisk reports pediatric obesity trial success amid market pressure

Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima

[QUIET] [BUSINESS] [US]

Veeva Systems life sciences technology expansion

2 clusters · 5 sources · last updated

Latest: Healthcare sector analysis: AbbVie, Novo Nordisk, and BridgeBio Pharma

Veeva Systems has expanded its life sciences technology suite through new pharmaceutical partnerships and product launches. Companies including Biogen and Regeneron Pharmaceuticals have selected Veeva Vault CRM to modern

Also covered in